Protagenic Therapeutics Inc. (PTIX)

[ferdilopje]

Atrinsic, Inc. (PINK:ATRN) has been steadily falling since August 2011. The company has two principal offerings: Full-service, performance-based online marketing solutions AND subscription content services. They use a unique cross-platform approach by combining the power of the Internet, mobile technology, traditional marketing and product development. Atrinsic is now one of the top digital performance marketing companies in the United States, which also provides exceptional entertainment content that draws 25 million unique visitors per month.

Despite this fact, the investor sentiment is terrible for this company. Take a look at their 52 week range of 0.01 – 7.68 and you realize that the vast majority of the losses have occurred in the last 6 months for ATRN, with little to no hope for current investors to ever see their investment back again.

Back on November 2, the company announced that they would be voluntarily delisting their common stock from the NASDAQ, needless to say this only fueled the downward spiral on the value of their company.

It’s an uphill battle for companies to emerge from this kind of darkness, when investors have made up their mind. Many day traders, and swing traders may stand a good chance at flipping this stock here and there when their market has an uptick, but that looks like it for the foreseeable future.